Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Borderi

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
The New Microbiologica|May 29, 2018
Managing the long surviving HIV patient: a proposal for a multidimensional first-level diagnostic assessmentMarco Borderi, Gioacchino Angarano, Andrea Antinori, et al.
Plos One|July 21, 2017
PrEP in Italy: The time may be ripe but who's paying the bill? A nationwide survey on physicians' attitudes towards using antiretrovirals to prevent HIV infectionAntonio Di Biagio, Niccolò Riccardi, Alessio Signori, et al.
The New Microbiologica|November 17, 2015
An update on integrase inhibitors: new opportunities for a personalized therapy? The NEXTaim ProjectMassimo Andreoni, Simone Marcotullio, Vincenzo Puro, et al.
The New Microbiologica|November 12, 2014
Recommendations for the use of hepatitis C virus protease inhibitors for the treatment of chronic hepatitis C in HIV-infected persons. A position paper of the Italian Association for the Study of Infectious and Tropical DiseaseOrlando Armignacco, Massimo Andreoni, Evangelista Sagnelli, et al.
Pharmacological Research|August 30, 2023
Pillars of long-term antiretroviral therapy successLucia Taramasso, Massimo Andreoni, Andrea Antinori, et al.
The New Microbiologica|October 20, 2010
Performance of genotypic tropism testing in clinical practice using the enhanced sensitivity version of Trofile as reference assay: results from the OSCAR Study GroupValentina Svicher, Roberta D'Arrigo, Claudia Alteri, et al.
The New Microbiologica|March 2, 2012
Performance of genotypic tropism testing on proviral DNA in clinical practice: results from the DIVA study groupValentina Svicher, Claudia Alteri, Marco Montano, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
The New Microbiologica|May 29, 2018
Managing the long surviving HIV patient: a proposal for a multidimensional first-level diagnostic assessmentMarco Borderi, Gioacchino Angarano, Andrea Antinori, et al.
Plos One|July 21, 2017
PrEP in Italy: The time may be ripe but who's paying the bill? A nationwide survey on physicians' attitudes towards using antiretrovirals to prevent HIV infectionAntonio Di Biagio, Niccolò Riccardi, Alessio Signori, et al.
The New Microbiologica|November 17, 2015
An update on integrase inhibitors: new opportunities for a personalized therapy? The NEXTaim ProjectMassimo Andreoni, Simone Marcotullio, Vincenzo Puro, et al.
The New Microbiologica|November 12, 2014
Recommendations for the use of hepatitis C virus protease inhibitors for the treatment of chronic hepatitis C in HIV-infected persons. A position paper of the Italian Association for the Study of Infectious and Tropical DiseaseOrlando Armignacco, Massimo Andreoni, Evangelista Sagnelli, et al.
Pharmacological Research|August 30, 2023
Pillars of long-term antiretroviral therapy successLucia Taramasso, Massimo Andreoni, Andrea Antinori, et al.
The New Microbiologica|October 20, 2010
Performance of genotypic tropism testing in clinical practice using the enhanced sensitivity version of Trofile as reference assay: results from the OSCAR Study GroupValentina Svicher, Roberta D'Arrigo, Claudia Alteri, et al.
The New Microbiologica|March 2, 2012
Performance of genotypic tropism testing on proviral DNA in clinical practice: results from the DIVA study groupValentina Svicher, Claudia Alteri, Marco Montano, et al.
Pageof 7